세계의 지질 나노입자 원료 시장 : 재료 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

REPORT HIGHLIGHT

Lipid Nanoparticle Raw Materials Market size was valued at US$ 245.98 Million in 2024, expanding at a CAGR of 5.90% from 2025 to 2032.

The Lipid Nanoparticle (LNP) Raw Materials Market focuses on the essential components used in producing lipid nanoparticles, which are vital for drug delivery systems, especially in mRNA-based therapies and vaccines. LNPs are composed of lipids such as ionizable lipids, phospholipids, cholesterol, and polyethylene glycol (PEG) lipids, which encapsulate and protect therapeutic molecules. The demand for these raw materials has surged due to the success of mRNA COVID-19 vaccines and advancements in gene therapy. Pharmaceutical and biotechnology companies are major consumers, driving market growth. Research into personalized medicine and cancer treatment also contributes to rising demand. North America and Europe dominate the market due to strong pharmaceutical industries, while Asia-Pacific shows rapid growth. Challenges include the high cost of raw materials and complex manufacturing processes. However, innovations in lipid chemistry and large-scale production techniques are addressing these issues. Overall, the market is expanding as LNPs become essential in next-generation therapeutics.

Lipid Nanoparticle Raw Materials Market- Market Dynamics

Rising demand for mRNA-based therapies and advanced drug delivery

Rising demand for mRNA-based therapies and advanced drug delivery is a key driver for the lipid nanoparticle (LNP) raw materials market. LNPs are crucial for delivering mRNA molecules safely and effectively into cells, enabling breakthroughs in treatments for various diseases. The success of mRNA COVID-19 vaccines has highlighted the potential of LNP-based delivery systems, driving further research and investment. Beyond vaccines, mRNA technology is being explored for cancer immunotherapy, rare genetic disorders, and personalized medicine, increasing the need for high-quality lipid components.

As pharmaceutical companies and biotech firms advance their mRNA pipelines, demand for ionizable lipids, phospholipids, and PEG lipids grows. Additionally, LNPs are gaining traction for delivering small interfering RNA (siRNA) and gene-editing tools like CRISPR, broadening their application scope. Continuous innovation in lipid formulations to enhance stability, efficacy, and safety further fuels market expansion. With increasing clinical trials and regulatory approvals for mRNA-based drugs, the market for LNP raw materials is experiencing steady growth.

Lipid Nanoparticle Raw Materials Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2025-2032)

Based on Material Type segmentation, Ionizable Lipids was predicted to show maximum market share in the year 2024

Based on application segmentation, mRNA vaccines were the leading application in 2024

Based on End-user segmentation, Pharmaceutical Companies vaccines were the leading End-user in 2024

On the basis of region, Asia Pacific was the leading revenue generator in 2024

Lipid Nanoparticle Raw Materials Market- Segmentation Analysis:

The Global Lipid Nanoparticle Raw Materials Market is segmented on the basis of Material Type, Application, End-user, and Region.

The market is divided into five categories based on Material Type: Ionizable Lipids, Phospholipids, Cholesterol, Polyethylene Glycol (PEG) Lipids, Helper Lipids. Ionizable lipids dominate the lipid nanoparticle (LNP) raw materials market due to their critical role in delivering genetic material, such as mRNA, into cells. These lipids are essential for forming stable nanoparticles that protect mRNA from degradation and facilitate efficient cellular uptake. Their unique property of being positively charged in acidic environments, such as endosomes, helps release therapeutic cargo into the cell. The success of mRNA-based COVID-19 vaccines has significantly boosted demand for ionizable lipids. Additionally, they are vital in emerging applications like gene editing, cancer immunotherapy, and rare disease treatments. Pharmaceutical companies prioritize high-purity ionizable lipids to ensure efficacy and safety in drug delivery. Continuous research is driving innovations to improve their biodegradability and reduce toxicity. With the rapid growth of mRNA-based therapies, ionizable lipids are expected to maintain their dominance in the LNP raw materials market.

The market is divided into five categories based on application: mRNA Vaccines, Gene Therapy, Oncology Drug Delivery, Protein and Peptide Delivery, Rare Disease Treatment. mRNA vaccines dominate the lipid nanoparticle (LNP) raw materials market, driven by their success in combating infectious diseases like COVID-19. LNPs play a vital role in protecting mRNA from degradation and ensuring efficient delivery into cells, making them essential for vaccine efficacy. The global success of COVID-19 vaccines has set a precedent for using LNP technology in future mRNA-based vaccines for influenza, Zika, and other diseases. Pharmaceutical companies are heavily investing in expanding mRNA vaccine pipelines, further increasing demand for LNP raw materials. Additionally, mRNA vaccines are gaining traction for personalized cancer vaccines, where they can train the immune system to target tumors. Continuous research is focused on improving LNP formulations to enhance stability, reduce toxicity, and enable storage at higher temperatures. With the growing focus on pandemic preparedness and rapid vaccine development, mRNA vaccines are expected to remain the leading application for LNP raw materials.

Lipid Nanoparticle Raw Materials Market- Geographical Insights

The Asia-Pacific region is experiencing rapid growth in the LNP raw materials market, driven by increasing pharmaceutical and biotechnology advancements. Countries like China, Japan, South Korea, and India are leading in mRNA-based research and development. Growing investments in vaccine production and gene therapy are boosting demand for lipid raw materials. Government initiatives supporting biotechnology innovation and local manufacturing are accelerating market expansion. The region has a strong network of contract development and manufacturing organizations, driving large-scale production. Rising clinical trials for mRNA-based treatments are further contributing to market growth. Academic institutions and research centers are actively collaborating with pharmaceutical firms to advance LNP technologies. Increasing healthcare expenditure and demand for personalized medicine are creating new opportunities. The region also benefits from a cost-effective manufacturing environment, attracting global companies for production partnerships. Overall, Asia-Pacific is emerging as a key hub for LNP raw materials due to innovation, investments, and growing mRNA applications.

China is a major contributor to the growth of the LNP raw materials market in Asia-Pacific, driven by advancements in biotechnology and pharmaceutical research. The country has witnessed a surge in mRNA-based vaccine development, especially during and after the COVID-19 pandemic, boosting demand for ionizable lipids, phospholipids, and PEG lipids. Strong government support through funding and policies promoting domestic drug manufacturing and innovation is accelerating market growth. China's growing network of contract development and manufacturing organizations (CDMOs) is driving large-scale production and export of LNP raw materials. Leading universities and research institutions are collaborating with biotech firms to develop next-generation drug delivery systems. Rising investments in gene therapy, cancer treatment, and rare disease research are further increasing demand for LNP components. The country's competitive manufacturing costs and advanced infrastructure are attracting global pharmaceutical partnerships. Additionally, increasing clinical trials and approvals for mRNA-based therapeutics are solidifying China's position as a key player in the global LNP raw materials market.

Lipid Nanoparticle Raw Materials Market- Competitive Landscape:

The lipid nanoparticle (LNP) raw materials market is highly competitive, with key players focusing on innovation, strategic collaborations, and expanding production capacities. CordenPharma and Avanti Polar Lipids are prominent providers of high-purity lipids, catering to major pharmaceutical companies for mRNA vaccine production. Merck KGaA and Evonik Industries lead in lipid manufacturing, leveraging advanced technologies to support large-scale production. Lipoid GmbH specializes in supplying phospholipids, essential for lipid formulations in drug delivery. Acuitas Therapeutics is renowned for its proprietary LNP technology, widely used in mRNA-based therapies. Genevant Sciences is advancing novel lipid formulations to improve delivery efficiency for gene-editing therapies.

Polymun Scientific provides customized lipid components and has strong ties with vaccine developers. Croda International, through its subsidiary Avanti Polar Lipids, is expanding its production capacity to meet growing global demand. Nippon Fine Chemical and IOI Oleo GmbH supply specialty lipids essential for stability and efficacy in formulations. T&T Scientific and Creative Biolabs focus on developing cost-effective lipid solutions for research and clinical use. Cayman Chemical and Echelon Biosciences support academic and industrial research with specialized lipid reagents.

Recent Developments:

In December 2023, BroadPharm completed a major expansion effort, doubled its facility, expanded advanced products and bioconjugation services, bolstered capacity, addressed rising pharmaceutical and biotech sector demands.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• CordenPharma
• Avanti Polar Lipids
• Precision NanoSystems
• Merck KGaA
• Lipoid GmbH
• Evonik Industries
• Genevant Sciences
• Acuitas Therapeutics
• Polymun Scientific
• Nippon Fine Chemical
• Cayman Chemical
• T&T Scientific
• IOI Oleo GmbH
• Croda International
• Creative Biolabs
• Echelon Biosciences
• PTS Inc.

GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET, BY MATERIAL TYPE- MARKET ANALYSIS, 2019 - 2032

• Ionizable Lipids
• Phospholipids
• Cholesterol
• Polyethylene Glycol (PEG) Lipids
• Helper Lipids

GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• mRNA Vaccines
• Gene Therapy
• Oncology Drug Delivery
• Protein and Peptide Delivery
• Rare Disease Treatment

GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Development and Manufacturing Organizations
• Research and Academic Institutions

GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Lipid Nanoparticle Raw Materials Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Lipid Nanoparticle Raw Materials Market Snippet by Material Type
  • 2.1.2. Lipid Nanoparticle Raw Materials Market Snippet by Application
  • 2.1.3. Lipid Nanoparticle Raw Materials Market Snippet by End-user
  • 2.1.4. Lipid Nanoparticle Raw Materials Market Snippet by Country
  • 2.1.5. Lipid Nanoparticle Raw Materials Market Snippet by Region
• 2.2. Competitive Insights

3. Lipid Nanoparticle Raw Materials Key Market Trends

• 3.1. Lipid Nanoparticle Raw Materials Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Lipid Nanoparticle Raw Materials Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Lipid Nanoparticle Raw Materials Market Opportunities
• 3.4. Lipid Nanoparticle Raw Materials Market Future Trends

4. Lipid Nanoparticle Raw Materials Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Lipid Nanoparticle Raw Materials Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Lipid Nanoparticle Raw Materials Market Landscape

• 6.1. Lipid Nanoparticle Raw Materials Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Lipid Nanoparticle Raw Materials Market - By Material Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Material Type, 2024 & 2032 (%)
  • 7.1.2. Ionizable Lipids
  • 7.1.3. Phospholipids
  • 7.1.4. Cholesterol
  • 7.1.5. Polyethylene Glycol (PEG) Lipids
  • 7.1.6. Helper Lipids

8. Lipid Nanoparticle Raw Materials Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
  • 8.1.2. mRNA Vaccines
  • 8.1.3. Gene Therapy
  • 8.1.4. Oncology Drug Delivery
  • 8.1.5. Protein and Peptide Delivery
  • 8.1.6. Rare Disease Treatment

9. Lipid Nanoparticle Raw Materials Market - By End-user

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
  • 9.1.2. Pharmaceutical Companies
  • 9.1.3. Biotechnology Companies
  • 9.1.4. Contract Development and Manufacturing Organizations
  • 9.1.5. Research and Academic Institutions

10. Lipid Nanoparticle Raw Materials Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Lipid Nanoparticle Raw Materials Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Lipid Nanoparticle Raw Materials Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.8. UK
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. UK Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.9. France
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. France Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.10. Italy
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. Italy Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.11. Spain
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.3. Spain Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.12. The Netherlands
    • 10.3.12.1. Overview
    • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.3. The Netherlands Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Overview
    • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.14. Russia
    • 10.3.14.1. Overview
    • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.3. Russia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.15. Poland
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Poland Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.16. Rest of Europe
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Lipid Nanoparticle Raw Materials Key Manufacturers in Asia Pacific
  • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. APAC Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.7. China
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. China Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.8. India
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. India Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.12. Indonesia
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Indonesia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.13. Thailand
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Thailand Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.5. Latin America (LATAM)
  • 10.5.1. Overview
  • 10.5.2. Lipid Nanoparticle Raw Materials Key Manufacturers in Latin America
  • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. LATAM Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa (MEA)
  • 10.6.1. Overview
  • 10.6.2. Lipid Nanoparticle Raw Materials Key Manufacturers in Middle East and Africa
  • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. MEA Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
  • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.8. UAE
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. UAE Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Lipid Nanoparticle Raw Materials Industry

• 11.1. Competitive Dashboard
  • 11.1.1. Competitive Benchmarking
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1. CordenPharma
  • 11.2.2. Avanti Polar Lipids
  • 11.2.3. Precision NanoSystems
  • 11.2.4. Merck KGaA
  • 11.2.5. Lipoid GmbH
  • 11.2.6. Evonik Industries
  • 11.2.7. Genevant Sciences
  • 11.2.8. Acuitas Therapeutics
  • 11.2.9. Polymun Scientific
  • 11.2.10. Nippon Fine Chemical
  • 11.2.11. Cayman Chemical
  • 11.2.12. T&T Scientific
  • 11.2.13. IOI Oleo GmbH
  • 11.2.14. Croda International
  • 11.2.15. Creative Biolabs
  • 11.2.16. Echelon Biosciences
  • 11.2.17. PTS Inc.

12. 360 Degree AnalystView

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us